TCSAM
GILD icon

Tyrus Capital S.A.M.’s Gilead Sciences GILD Stock Holding History

Tyrus Capital S.A.M.’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33,000
Closed -$2.36M – 29
2016
Q4 		$2.36M Buy
+33,000
New +$2.45M 0.59% 16
2015
Q4 		– Sell
-126,000
Closed -$12.4M – 35
2015
Q3 		$12.4M Sell
126,000
-389,000
-76% -$43.2M 2.06% 11
2015
Q2 		$60.3M Buy
515,000
+133,300
+35% +$14.6M 11.3% 3
2015
Q1 		$37.5M Buy
+381,700
New +$38.8M 4.17% 10

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Tyrus Capital S.A.M.'s GILD Position: Q1 2017 in Review

Tyrus Capital S.A.M. sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 33,000 shares — an estimated $2.36M sold.

Tyrus Capital S.A.M. first reported a position in GILD in Q1 2015 and held it in 4 quarters. The position peaked at $60.3M in Q2 2015. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Tyrus Capital S.A.M. reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Tyrus Capital S.A.M. sold 33,000 Gilead Sciences shares in Q1 2017, an estimated $2.36M.
  • Tyrus Capital S.A.M. first reported a position in Gilead Sciences in Q1 2015 and held it in 4 quarters.
  • Tyrus Capital S.A.M.'s Gilead Sciences position peaked at $60.3M in Q2 2015.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Tyrus Capital S.A.M.'s 13F filing for Q1 2017, filed 15 May 2017.